COVID-19 vaccine rollout: A selection of stories, videos, interactives

The world's largest COVID-19 vaccine drive is set to roll out today across India. The government has activated a systematic and complex logistics and supply chain to take the vaccine from its point of origin to the citizens.
Two vaccines, Covishield and Covaxin, have been approved for restricted emergency use in India. Covishield, developed by Oxford University and AstraZeneca, is being produced by Serum Institute of India, while Bharat Biotech's Covaxin has been indigenously developed.
The first consignment of Covishield reached 13 locations on Tuesday while that of Covaxin reached 11 cities a day later. In the initial phase, 30 crore Indans will get it for free: first, one crore health workers and two crore frontline workers, followed by those above 50 years age and with co-morbid conditions. On Day 1, three lakh health workers will receive the vaccine.

Things to know before getting COVID-19 vaccine

https://youtu.be/pDocaUI4KqE

COVID-19: When will it end? Two months or so, says Levitt’s Model

The COVID-19 pandemic will end in most of India by two-and-a-half months, says Bhaskaran Raman and his team from IIT Bom...

Now that India has approved 2 COVID-19 vaccines, what next?

In the vaccine race amid coronavirus pandemic, India made a big leap on Sunday by giving approval to two vaccines for restricted emergency use, indicating an imminent inoculation in the country

India wants intellectual property on COVID vaccine suspended. Here’s why

The countries developing Covid-19 vaccines are now backing their right to protect their vaccines and drugs, which is their intellectual property. In this scenario, how do the poorer nations with no vaccine developing resources get the cure?

Which COVID-19 vaccine can India afford?

https://youtu.be/tISWkl90SmQ

Vaccine nationalism: Russia ushers in relic of Cold War era races

In what can arguably be considered as a reference to the different technology races of the Cold War period, Russia has gone on to name the CoV2 vaccine ‘Sputnik V’. This can be considered as signalling towards victory in the vaccine race by Russia.
  • Win Games Ad
  • Choco-pie Ad
Open COVID-19 STATS